Atlas and Glaxo back Austrian biotech business

ProtAffin raises €14.1m for anti-inflammatory drug development

1 April 2009•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.